Greenlane Holdings lands at 28 on the CIN composite, a Underweight outcome with conviction of 2/5. The composite is a fixed blend of four pillars — fundamentals at 35 percent, regulatory at 25, market at 25, and editorial at 15 — and each contribution is inspectable. The strongest contribution comes from the regulatory pillar at 49, and pulls the composite toward the lower edge of the band. Fundamentals lags at 2, softening what would otherwise be a stronger reading.
The observable inputs tell a straightforward story: reported revenue growth of -69.5 percent year over year, an operating margin of -1243.8 percent. Every figure is auditable in the accompanying pillar table. Every input flowing into the pillar table comes from primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, filtered through CIN newsroom density. The 336-ticker CIN universe is scored deterministically, so Greenlane Holdings can be compared against the US operator peer set on identical inputs, refreshed on the ingest cycle.
The rating turns on regulatory pace. Filings landing at above the trailing-90-day cadence, combined with an unblemished enforcement record, would carry Greenlane Holdings above the Underweight anchor; a lull would soften the read.
Bullish and Bearish Analyst Opinions for Greenlane Holdings (GNLN)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Greenlane Holdings (GNLN), a cannabis-sector equity listed on NASDAQ. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Analyst average price target $3.92.
CIN editorial stance: Neutral / Wait. Mixed data profile. Risk factors: deep drawdown. (2 bullish signals, 2 bearish signals.)
Bullish and bearish analyst opinions for Greenlane Holdings, Inc. (GNLN)
Bullish view. Greenlane Holdings has strategic distribution and brand relationships across the accessories and consumption space that bulls argue are underpriced at current market cap.
Bearish view. The bearish thesis centers on going-concern risk flagged in filings, dilution history, and dependence on a still-shrinking traditional retail channel.
5-year weekly price history, intraday quotes, and 52-week range for GNLN are maintained by Cannabis Investor News and refreshed throughout the trading day.